Insmed IncorporatedINSM
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $819.56M, growing 115.1% year-over-year. TTM net income stood at $-1.18B (16.8% contraction). Quarterly EBITDA was $-153.32M and operating income was $-153.32M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze INSM growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters